Annals of Surgical Oncology

, Volume 26, Issue 10, pp 3109–3114 | Cite as

Reducing Narcotic Prescriptions in Breast Surgery: A Prospective Analysis

  • Betty Fan
  • Stephanie A. Valente
  • Sabrina Shilad
  • Zahraa Al-Hilli
  • Diane M. Radford
  • Chao Tu
  • Stephen R. GrobmyerEmail author
Breast Oncology



No clear standards regarding number or type of narcotics for adequate postoperative pain control have been established in breast surgery. The authors of this study reviewed their opioid-prescribing patterns and implemented a planned change, evaluated the effectiveness of a departmental practice adjustment, and prospectively evaluated patient narcotic usage.


The narcotic prescriptions for 100 consecutive breast surgery patients were reviewed to establish baseline postoperative narcotic-prescribing patterns. The median of narcotics prescribed was used to educate surgeons and implement a planned change in prescribing practices. Data on narcotic prescriptions for 100 consecutive breast surgery patients then were prospectively collected, and the number of pain pills the patients actually took after discharge was recorded using a standardized template.


A baseline review of narcotic-prescribing practices showed that the median number of pills given was 15 for excisional biopsy/lumpectomy, 20 for mastectomy, and 28 for mastectomy with reconstruction. After departmental education, the median number decreased to 10 for excisional biopsy/lumpectomy (p < 0.01) and 25 for mastectomy with reconstruction (p < 0.01). Prospective recording of patient usage compared with the prescribed number of pills indicated that most prescribed pills were not used, with the excisional biopsy or lumpectomy patients using a median of 1 pill (p < 0.01), the mastectomy patients using a median of 3 pills (p < 0.01), and the mastectomy with reconstruction patients using a median of 18 pills (p < 0.01) postoperatively. Only three patients, all of whom had breast reconstruction performed, required a refill of narcotics.


Successful reduction in narcotic prescriptions can be implemented for breast surgery patients. Further reductions in narcotic prescriptions may be feasible based on prospective collected patient usage.



There are no conflicts of interest.


  1. 1.
    Madras BK. The surge of opioid use, addiction, and overdoses. JAMA Psychiatry. 2017. Scholar
  2. 2.
    Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief. 2017;(294):1–8.Google Scholar
  3. 3.
    Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths–United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67:2013–7. Scholar
  4. 4.
    Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths–United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016. Scholar
  5. 5.
    Hart AM, Broecker J, Kao L, Losken A. Opioid usage following outpatient breast surgery. Plast Reconstr Surg. 2018. Scholar
  6. 6.
    Hill MV, Mcmahon ML, Stucke RS, Barth RJ. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265:709–14. Scholar
  7. 7.
    Kumar K, Gulotta LV, Dines JS, et al. Unused opioid pills after outpatient shoulder surgeries given current perioperative prescribing habits. Am J Sports Med. 2017. Scholar
  8. 8.
    Tan WH, Yu J, Feaman S, et al. Opioid medication use in the surgical patient: an assessment of prescribing patterns and use. J Am Coll Surg. 2018. Scholar
  9. 9.
    Bates C, Laciak R, Southwick A, Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption, and disposal in urological practice. J Urol. 2011;185:551–5. Scholar
  10. 10.
    Shei A, Rice JB, Kirson NY, et al. Sources of prescription opioids among diagnosed opioid abusers. Curr Med Res Opin. 2015. Scholar
  11. 11.
    Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? Clin J Pain. 2014. Scholar
  12. 12.
    Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008–2011. JAMA Intern Med. 2014. Scholar
  13. 13.
    Park KU, Kyrish K, Terrell J, et al. Surgeon perception versus reality: opioid use after breast cancer surgery. J Surg Oncol. 2019;119:909–15. Scholar
  14. 14.
    Fujii MH, Hodges AC, Russell RL, et al. Post-discharge opioid prescribing and use after common surgical procedure. J Am Coll Surg. 2018;226:1004–12. Scholar
  15. 15.
    Hill MV, Stucke RS, Billmeier SE, Kelly JL, Barth RJ. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg. 2018;226:996–1003. Scholar
  16. 16.
    Overton HN, Hanna MN, Bruhn WE, et al. Opioid-prescribing guidelines for common surgical procedures: an expert panel consensus. J Am Coll Surg. 2018;227:411–8. Scholar
  17. 17.
    Michigan-OPEN. 2019. New opioid-prescribing recommendations for 2019. Retrieved 20 April 2019 at
  18. 18.
    Barker JC, DiBartola K, Wee C, et al. Preoperative multimodal analgesia decreases post-anesthesia care unit narcotic use and pain scores in outpatient breast surgery. Plast Reconstr Surg. 2018. Scholar
  19. 19.
    Batdorf NJ, Lemaine V, Lovely JK, et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthetic Surg. 2015. Scholar
  20. 20.
    Parsa FD, Cheng J, Stephan B, et al. Bilateral breast reduction without opioid analgesics: a comparative study. Aesthetic Surg J. 2017;37:892–9. Scholar
  21. 21.
    Rojas KE, Manasseh DM, Flom PL, et al. A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge. Breast Cancer Res Treat. 2018. Scholar
  22. 22.
    Campbell I, Cavanagh S, Creighton J, et al. To infiltrate or not? Acute effects of local anaesthetic in breast surgery. ANZ J Surg. 2015;85:353–7. Scholar
  23. 23.
    Byager N, Hansen MS, Mathiesen O, Dahl JB. The analgesic effect of wound infiltration with local anaesthetics after breast surgery: a qualitative systematic review. Acta Anaesthesiol Scand. 2014. Scholar
  24. 24.
    Zielinski J, Jaworski R, Smietanska I, Irga N, Wujtewicz M, Jaskiewicz J. A Randomized, double-blind, placebo-controlled trial of preemptive analgesia with bupivacaine in patients undergoing mastectomy for carcinoma of the breast. Med Sci Monit. 2011;17(10):CR589–97.CrossRefGoogle Scholar
  25. 25.
    Gatherwright J, Knackstedt RW, Ghaznavi AM, et al. Prospective, randomized, controlled comparison of bupivacaine versus liposomal bupivacaine for pain management after unilateral delayed deep inferior epigastric perforator free flap reconstruction. Plast Reconstr Surg. 2018. Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Betty Fan
    • 1
  • Stephanie A. Valente
    • 1
  • Sabrina Shilad
    • 1
  • Zahraa Al-Hilli
    • 1
  • Diane M. Radford
    • 1
  • Chao Tu
    • 2
  • Stephen R. Grobmyer
    • 1
    Email author
  1. 1.Division of Breast Surgery, Department of General SurgeryCleveland ClinicClevelandUSA
  2. 2.Department of Quantitative Health SciencesCleveland ClinicClevelandUSA

Personalised recommendations